Name | 5-bromo-2-methyl-8-nitro-3,4-dihydro-1H-isoquinoline |
---|---|
Synonyms |
5-Brom-2-methyl-8-nitro-1,2,3,4-tetrahydroisochinolin
5-bromo-1,2,3,4-tetrahydro-2-methyl-8-nitroisoquinoline 5-Bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline 2-methyl 5-bromo-8-nitro-1,2,3,4-tetrahydroisoquinoline Isoquinoline, 5-bromo-1,2,3,4-tetrahydro-2-methyl-8-nitro- 5-bromo-N-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline Isoquinoline,5-bromo-1,2,3,4-tetrahydro-2-methyl-8-nitro N-methyl 5-bromo-8-nitro-1,2,3,4-tetrahydroisoquinoline |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 345.7±42.0 °C at 760 mmHg |
Molecular Formula | C10H11BrN2O2 |
Molecular Weight | 271.111 |
Flash Point | 162.9±27.9 °C |
Exact Mass | 270.000397 |
PSA | 49.06000 |
LogP | 2.40 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.612 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2933499090 |
~81% 104737-00-0 |
Literature: MEMORY PHARMACEUTICALS CORPORATION Patent: US2008/200471 A1, 2008 ; Location in patent: Page/Page column 45; 46 ; US 20080200471 A1 |
~97% 104737-00-0 |
Literature: PAINCEPTOR PHARMA CORPORATION Patent: WO2008/144931 A1, 2008 ; Location in patent: Page/Page column 86 ; WO 2008/144931 A1 |
~93% 104737-00-0 |
Literature: Rey, Max; Vergnani, Tiziana; Dreiding, Andre S. Helvetica Chimica Acta, 1985 , vol. 68, p. 1828 - 1834 |
~46% 104737-00-0 |
Literature: BIGGE, CHRISTOPHER F.; MALONE, THOMAS C.; WATJEN, FRANK Patent: US2003/114422 A1, 2003 ; |
~% 104737-00-0 |
Literature: Bigge; Malone; Boxer; Nelson; Ortwine; Schelkun; Retz; Lescosky; Borosky; Vartanian; Schwarz; Campbell; Robichaud; Watjen Journal of Medicinal Chemistry, 1995 , vol. 38, # 19 p. 3720 - 3740 |
~% 104737-00-0 |
Literature: Bigge; Malone; Boxer; Nelson; Ortwine; Schelkun; Retz; Lescosky; Borosky; Vartanian; Schwarz; Campbell; Robichaud; Watjen Journal of Medicinal Chemistry, 1995 , vol. 38, # 19 p. 3720 - 3740 |
Precursor 5 | |
---|---|
DownStream 1 | |
HS Code | 2933499090 |
---|---|
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |